bpc-157 human clinical trials evidence review fda warning and the Difference Between an Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded FDA Scientists Warn Against Expanded
Description
This rash is easy to confuse with other skin problems

Reported side effects from supplementation are rare and usually mild: occasional nausea, headache, or mild rash

BPC-157 is classified by WADA in the S0 Unapproved Substances category, meaning it is prohibited in professional and competitive sport regardless of administration route

Thats why we encourage you to pair B12 therapy with smart lifestyle changes for optimal results